超脉冲二氧化碳点阵激光治疗稳定期白癜风的临床效果
作者:
作者简介:

潘武林(1971.8-),男,湖北武汉人,本科,副主任医师,主要从事皮肤病性病方向研究

中图分类号:

R758.4+1


The Clinical Effect of Ultra-pulsed Carbon Dioxide Lattice Lase in the Treatment of Stable Vitiligo
Author:
  • 摘要
  • | |
  • 访问统计
  • |
  • 参考文献 [15]
  • |
  • 相似文献 [20]
  • | | |
  • 文章评论
    摘要:

    目的 探究超脉冲二氧化碳点阵激光治疗稳定期白癜风的临床效果。方法 以我院2019年1月-2020年10月收治的80例稳定期白癜风患者为研究对象,通过简单随机化法分为对照组(n=40)和试验组(n=40),对照组采用常规药物治疗,试验组则在对照组基础实施超脉冲二氧化碳点阵激光治疗,比较两组治疗效果、生活质量评分、炎性因子水平及不良反应发生情况。结果 试验组的总有效率为90.00%,高于对照组的70.00%(P<0.05);两组治疗后生活质量评分均高于治疗前,且试验组生活质量评分高于对照组(P<0.05);两组炎性因子水平均低于治疗前,且试验组低于对照组(P<0.05);两组不良反应发生率比较,差异无统计学意义(P>0.05)。结论 与常规药物治疗相比,超脉冲二氧化碳点阵激光治疗效果更佳,可有效改善患者生活质量,降低炎性因子水平,且不会增加不良反应,是一种安全、有效的治疗方案。

    Abstract:

    Objective To explore the clinical effectof ultra-pulsed carbon dioxide lattice laser in the treatment of stable vitiligo. Methods A total of 80 patients with stable vitiligo admitted to our hospital from January 2019 to October 2020 were divided into control group (n=40) and experimental group (n=40) by simple randomization method. The control group was treated with conventional drugs, and the experimental group was treated with ultra-pulsed carbon dioxide lattice laser on the basis of the control group. The therapeutic effect,quality of life score, inflammatoryfactor level and adverse reactions were compared between the two groups. Results The total effectiverate of the experimental group was 90.00%, which was higher than 70.00% of the control group (P<0.05). The quality of life scores of the two groups after treatment were higher than those before treatment, and the quality of life score of the experimental group was higher than that of the control group (P<0.05). The levels of inflammatoryfactors in the two groups were lower than those before treatment, and the experimental group was lower than the control group (P<0.05). There was no significan differencein the incidence of adverse reactions between the two groups (P>0.05). Conclusion Compared with conventional drug therapy, ultra-pulsed carbon dioxide lattice laser has better therapeutic effect,which can effectivelyimprove the quality of life, reduce the level of inflammatory factors, and does not increase adverse reactions. It is a safe and effective treatmen

    参考文献
    [1] 薛峤,丁浩,魏梅,等.复方卡力孜然酊联合点阵二氧化碳激光治疗稳定期肢端白癜风疗效观察[J].中国医疗美容,2020,10(2):52-55.
    [2]曾明凤,龙玲珑,伊力努尔?哈力甫,等.观察CO2点阵激光联合308nm准分子激光治疗躯干部位白癜风的效果及不良反应[J].特别健康,2020(18):136.
    [3] 刘真真.二氧化碳点阵激光联合他克莫司软膏治疗局限型白癜风的效果[J].中国民康医学,2020,32(18):31-33.
    [4] 张园程,尹璐,刘宇博,等.308 nm准分子光联合CO2点阵激光治疗稳定期白癜风临床效果观察[J].临床军医杂志,2021,49(7):778-779.
    [5] 周程.二氧化碳点阵激光联合复方甘草酸苷胶囊治疗局限性白癜风的临床效果分析[J].医药前沿,2019,9(20):87-88.
    [6] 陈海燕,韩春雷,叶衍宁,等.复方槐花补骨脂酊联合二氧化碳点阵激光治疗稳定期肢端型白癜风的疗效观察[J].中国基层医药,2019,26(7):848-851.
    [7] E?me P,Gür Aksoy G,El?in G.No Additional Benefit of Combining Fractional Carbon Dioxide Laser With Narrow-Band Ultraviolet B Phototherapy for Vitiligo: A Randomized Prospective Study With Half-Body Side Comparison[J].Dermatologic surgery,2019,45(12):1627-1634.
    [8] 杨谦,何荣国,邬运学,等.二氧化碳点阵激光联合他克莫司对白癜风患者血清炎性因子表达的影响[J]. 赣南医学院学报,2020,40(1):69-71,80.
    [9]郑欣丽,亓玉青,任帅.308nm准分子光、CO2点阵激光联合治疗白癜风的临床效果及安全性分析[J].中国医疗美容,2017,7(5):46-48.
    [10]Liu L,Wu Y,Zhang J,et al.Ablative fractional CO2 laser aided delivery of long-acting glucocorticoid in the treatment of acral vitiligo: a multicenter, prospective, self-bilateral controlled study[J].The Journal of dermatological treatment,2019,30(4):320-327.
    [11]钱雯,司晨琛,陈奕鹤,等.点阵CO2激光联合外用药物治疗稳定期白癜风临床疗效及相关影响因素分析[J].中国美容医学,2021,30(3):24-26.
    [12]吴玲艳,潘延斌,邓桂艳,等.CO2点阵激光及他克莫司联合复方甘草酸苷片治疗稳定期非节段型白癜风的效果观察[J].广西医学,2021,43(7):882-884.
    [13]林妙莉,刘远针,刘娟慧,等.CO2FL与复方倍他米松封包及308nm准分子激光联合治疗稳定期白癜风的临床效果及安全性分析[J].中外医学研究,2021,19(22):45-48.
    [14]康娟,郝树媛,台永红,等.CO2点阵激光及窄谱中波紫外线联合卤米松治疗白癜风的疗效及安全性[J].中国实用医刊,2020,47(12):51-54.
    [15]林茂,张德利,刁庆春.毫火针联合补肾活血方对寻常型进展期白癜风的疗效及对血清可溶性细胞间黏附分子-1水平的影响[J].世界中医药,2019,14(5):1306-1309.
    引证文献
    网友评论
    网友评论
    分享到微博
    发 布
引用本文

潘武林,陈 黎,张小为,等.超脉冲二氧化碳点阵激光治疗稳定期白癜风的临床效果[J].医学美学美容,2022,31(2):37-40.

复制
分享
文章指标
  • 点击次数:301
  • 下载次数: 0
  • HTML阅读次数: 0
  • 引用次数: 0
历史
  • 在线发布日期: 2022-08-25